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INTRODUCTION
Elastography is a promising method in the assessment of 
differences in tissue stiffness and in distinguishing benign 
from malignant lesions [1-3]. This method, utilizing a clinical 
concept that malignant lesions are generally harder than nor-
mal surrounding tissues, has been used to examine several or-
gans, such as the thyroid, liver, pancreas, prostate, and breast 
[4-7]. Among the several types of elastography, shear-wave 
elastography (SWE) has been developed to measure quantita-
tive elasticity values using the acoustic radiation force induced 
by the ultrasound beam itself [5,8]. The acoustic radiation 
force induces mechanical waves, including shear waves, which 
propagate transversely through the tissues [9,10]. The SWE 
image is displayed by mapping a color that represents the de-
gree of elasticity in a conventional B-mode ultrasound image 
[4].
In this study, we aimed to determine whether SWE could 
be used to predict metastasis in excised axillary lymph nodes 
because the presence of metastatic foci increases the stiffness 
of lymph nodes via increased cell density (tumor cells are 
tightly packed), stromal, and cytoskeletal stiffness [3]. Several 
studies have examined whether SWE can predict nodal me-
tastasis in preoperative evaluation in vivo [11-14] or ex vivo [1]. 
Thus, we evaluated the feasibility of using ex vivo SWE intra-
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Purpose: There is still a clinical need to easily evaluate the meta-
static status of lymph nodes during breast cancer surgery. We 
hypothesized that ex vivo shear-wave elastography (SWE) would 
predict precisely the presence of metastasis in the excised 
lymph nodes. Methods: A total of 63 patients who underwent 
breast cancer surgery were prospectively enrolled in this study 
from May 2014 to April 2015. The excised axillary lymph nodes 
were examined using ex vivo SWE. Metastatic status was con-
firmed based on the final histopathological diagnosis of the per-
manent section. Lymph node characteristics and elasticity val-
ues measured by ex vivo SWE were assessed for possible asso-
ciation with nodal metastasis. Results: A total of 274 lymph 
nodes, harvested from 63 patients, were examined using ex vivo 
SWE. The data obtained from 228 of these nodes from 55 pa-
tients were included in the analysis. Results showed that 187 
lymph nodes (82.0%) were nonmetastatic and 41 lymph nodes 
(18.0%) were metastatic. There was significant difference be-
tween metastatic and nonmetastatic nodes with respect to the 
mean (45.4 kPa and 17.7 kPa, p<0.001) and maximum (55.3 
kPa and 23.2 kPa, p<0.001) stiffness. The elasticity ratio was 
higher in the metastatic nodes (4.36 and 1.57, p<0.001). Meta-
static nodes were significantly larger than nonmetastatic nodes 
(mean size, 10.5 mm and 7.5 mm, p<0.001). The size of meta-
static nodes and nodal stiffness were correlated (correlation co-
efficient of mean stiffness, r=0.553). The area under curve of 
mean stiffness, maximum stiffness, and elasticity ratio were 
0.794, 0.802, and 0.831, respectively. Conclusion: Ex vivo SWE 
may be a feasible method to predict axillary lymph node metas-
tasis intraoperatively in patients undergoing breast cancer sur-
gery. 
Key Words: Axilla, Breast neoplasms, Elasticity imaging techniques, Lymphatic 
metastasis 
Correspondence to: Joon Jeong
Department of Surgery, Gangnam Severance Hospital, Yonsei University 
College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea
Tel: +82-2-2019-3379, Fax: +82-2-3462-5994
E-mail: gsjjoon@yuhs.ac
*These authors contributed equally to this work.
This work was supported by a grant from the research fund of Yonsei 
University Medical College, Seoul, Korea (6-2014-0199).
Received: February 23, 2018 Accepted: April 20, 2018
Journal of        Breast
Cancer
Ex Vivo Shear-Wave Elastography to Predict Axillary Lymph Node Metastasis 191
https://doi.org/10.4048/jbc.2018.21.2.190 http://ejbc.kr
operatively to predict metastatic involvement of excised 
lymph nodes in patients undergoing surgery for breast cancer.
METHODS
Patients
A total of 63 patients who underwent mastectomy or breast-
conserving surgery with axillary lymph node evaluation for 
breast cancer were prospectively enrolled in this study from 
May 2014 to April 2015. A total of 274 axillary lymph nodes 
obtained form 63 patients were evaluated using ex vivo SWE. 
Patients who received neoadjuvant chemotherapy (n= 2) or 
whose SWE was performed poorly (n= 6) were excluded. Fi-
nally, we analyzed a total of 228 lymph nodes excised from 55 
patients; this included sentinel lymph nodes (SLNs), non-
SLNs, and other axillary lymph nodes. Of these 55 patients, 
four patients were clinically lymph node-positive and six pa-
tients were diagnosed with axillary lymph node metastasis in 
preoperative fine needle aspiration. Two of the clinically lymph 
node-positive patients were also identified to have lymph node 
metastases by preoperative fine needle aspiration. SLN biopsy 
under the guidance of technetium 99mTc-labeled tin colloid de-
tected by gamma probe and frozen section evaluation during 
the surgery were performed in clinically lymph node-negative 
patients. The lymph node with radioactive uptake equal to or 
greater than 10% of the highest radioactive lymph node was 
defined as the SLN. Axillary lymph node dissection was per-
formed in patients who were clinically axillary lymph node-
positive or with axillary lymph node metastasis confirmed by 
preoperative fine needle aspiration or intraoperative SLN bi-
opsy. The metastatic status of the excised lymph nodes was 
confirmed with histological examination of the permanent 
pathological section. Nodal characteristics and elasticity values 
measured by ex vivo SWE were analyzed to determine whether 
they were correlated with nodal metastasis.
The study was conducted in accordance with Good Clinical 
Practice guidelines and the Declaration of Helsinki. Informed 
consent was obtained, and ethics approval for this study was 
granted by the Institutional Review Board of Yonsei Universi-
ty, Seoul, Republic of Korea (IRB number: 3-2015-0017).
B-mode ultrasound and shear-wave elastography 
The excised axillary lymph nodes were sent to the ultra-
sound room before the pathologic evaluation of the frozen 
sections. B-mode ultrasound and SWE examinations using 
the Aixplorer ultrasound system (SuperSonic Imagine, Aix-
en-Provence, France) and its ShearWaveTM elastography mode 
were performed independently by two expert radiologists us-
ing a 4–15-MHz linear transducer. During the B-mode ultra-
sound and SWE examination, the radiologist needs to handle 
the excised lymph nodes carefully so as not to exert pressure 
on them with the ultrasound transducer. First, the specimen 
was examined with a B-mode ultrasound using a sufficient 
amount of contact jelly to avoid artefactual stiffness. The di-
ameter of the axillary lymph node that appeared to be hy-
poechoic compared with the adjacent fat tissue was measured 
(Supplementary Figure 1A, available online). Then, the SWE 
images of at least two longitudinal planes was obtained. The 
region-of-interest (ROI) box (Q-BoxTM; SuperSonic Imagine) 
of the system was drawn to include the lesion and surround-
ing normal tissue. Overlaid on the gray-scale image was a 
semi-transparent color map of tissue stiffness with a range 
from dark blue, indicating the lowest stiffness, to red, indicat-
ing the highest stiffness (0–180 kPa). Similar to the appear-
ance of malignant breast lesions during SWE, metastatic 
lymph nodes show the “stiff rim sign,” which is increased stiff-
ness at the lesion’s margin and adjacent tissue on the color 
elastic map. After few seconds of immobilization to allow the 
SWE image to stabilize, elasticity values (maximum and mean 
stiffness values [kPa]) were measured by placing a fixed 2-mm 
Table 1. Clinicopathologic characteristics of the 55 patients
Characteristic No. (%)
Age (yr)* 49 (31–69)
Tumor size (cm)* 1.75 (0.10–3.60)
ER
   Positive 39 (70.9)
   Negative 16 (29.1)
PR
   Positive 32 (58.2)
   Negative 23 (41.8)
HER2
   Positive 21 (38.2)
   Negative 34 (61.8)
T stage
   Tis 2 (3.6)
   T1mi 2 (3.6)
   T1 31 (56.4)
   T2 20 (36.4)
N stage
   N0 28 (50.9) 
   N1 19 (34.5)
   N2 6 (10.9)
   N3 2 (3.6)
Histologic grade
   I 7 (12.7)
   II 25 (45.5)
   III 20 (36.4)
   No identified 3 (5.5)
ER=estrogen receptor; PR=progesterone receptor; HER2=human epider-
mal growth factor receptor 2.
*Median (range). 
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circular ROI on the stiffest region of the excised axillary 
lymph node [15]. The ratio of elasticity of lymph nodes to that 
of the adjacent subcutaneous adipose tissue was calculated 
automatically when the first ROI was placed on the stiffest re-
gion of excised lymph node, and the other ROI was immedi-
ately set over the adjacent fat tissue (Supplementary Figure 1B, 
available online). In addition, the imaging system automati-
cally calculated the mean and maximum values of elasticity in 
kilopascals. Two radiologists analyzed the SWE images; both 
were blinded to the diagnosis and clinicopathologic factors. 
Pathologic evaluation of excised lymph nodes
The excised axillary lymph nodes were thinly sectioned (at 
2–3 mm) and all slices were examined. The size of metastatic 
lesion within the excised node was reported according to the 
staging system of American Joint Committee on Cancer as 
follows: > 2 mm, macro-metastasis; 0.2–2.0 mm, micro-me-
tastasis; and < 0.2 mm, isolated tumor cells [16].
Statistical analysis
The mean elasticity values were compared between non-
metastatic and metastatic nodes using the independent two 
sample t-test. Multivariable analysis was performed using bi-
nary logistic regression model adjusted for statistically signifi-
cant factors in the univariable analysis. Correlation between 
elasticity values and nodal metastases were examined using 
Table 2. Ex vivo SWE values and characteristics between nonmetastatic and metastatic axillary lymph nodes in uni- and multivariable models
Characteristic
Univariable model Multivariable model
OR (95% CI) p-value OR (95% CI) p-value
Node size (mm) 1.186 (1.091–1.288) <0.001 1.162 (1.048–1.287) 0.004
Mean stiffness (kPa) 1.065 (1.043–1.089) <0.001 1.035 (1.006–1.065) 0.019
Ratio 2.332 (1.763–3.085) <0.001 1.702 (1.194–2.428) 0.003
SWE=shear-wave elastography; OR=odds ratio; CI=confidence interval. 
Figure 1. Characteristics of metastatic and nonmetastatic lymph node. Box plot showing size (A), mean stiffness (B), max stiffness (C), and the elas-
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Pearson correlation analysis. The Youden method was used to 
identify the cutoff values. Receiver operating characteristic 
curve (ROC) analysis of nodal size and elasticity values ob-
tained via SWE for metastatic lymph nodes was performed. A 
p-value < 0.05 was considered to indicate statistical signifi-
cance, and 95% confidence intervals (CIs) are given. The soft-
ware programs used to perform these analyses were SPSS ver-
sion 20.0 (IBM Corp., Armonk, USA), SAS version 9.2 (SAS 
Institute, Cary, USA), and R package version 2.9.2.
RESULTS
A total of 274 lymph nodes, harvested from 63 breast can-
cer patients, were examined using ex vivo SWE. Of these 274 
lymph nodes, 228 (from 55 patients) were eligible for our 
study. The median patient age was 49 years (range, 31–69 
years). The median tumor size was 1.75 cm (range, 0.1–3.6 
cm). Estrogen receptor (ER) and human epidermal growth 
factor receptor 2 (HER2) were positive in 39 (70.9%) and 21 
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Figure 3. Receiver operating characteristic (ROC) curve analysis of size, mean stiffness, max stiffness, and elasticity ratio. (A) Lymph nodes with mi-
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(38.2%) patients, respectively. The baseline clinicopathologic 
characteristics are presented in Table 1. Of the 228 lymph 
nodes, 187 (82.0%) were nonmetastatic and 41 (18.0%) were 
metastatic. Metastatic lymph nodes were significantly larger 
than nonmetastatic lymph nodes (mean size, 10.5 mm and 7.5 
mm, respectively, p< 0.001). The size of metastatic foci ranged 
from 3.0 mm to 21.5 mm with a mean of 9.3 mm (Supple-
mentary Table 1, available online). 
There was significant correlation between nodal metastasis 
and the elasticity values, including mean and maximum stiff-
ness (kPa). The mean stiffness (45.4 kPa vs. 17.7 kPa) (Figure 
1), maximum stiffness (55.3 kPa vs. 23.2 kPa), and elasticity 
ratio (4.36 vs. 1.57) of the metastatic lymph nodes were signif-
icantly higher than those of the nonmetastatic nodes. In the 
multivariate analysis, nodal size and elasticity values (mean 
stiffness and elasticity ratio) were associated with nodal me-
tastasis (Table 2). In addition, the mean (r= 0.553, p<  0.001) 
and maximum (r= 0.497, p= 0.001) stiffness were significant-
ly correlated with the size of the metastatic foci within the 
lymph nodes (Figure 2). 
ROC curves and calibration plots were used to assess the 
discriminatory power of each elasticity value to identify nodal 
metastasis (Supplementary Figures 2 and 3, available online). 
The area under curve (AUC) for mean stiffness was 0.794 
(95% CI, 0.710–0.879; p < 0.001). The AUC values for the 
maximum stiffness and the elasticity ratio were 0.802 and 
0.831, respectively (Figure 3A).
When the mean stiffness cutoff point of 30.6 kPa was used, 
the test showed high specificity (90.9%) and accuracy (85.1%) 
values. Other cutoff points were 8.9 mm for node size, 38.6 
kPa for maximum stiffness, and 2.37 for the elasticity ratio 
(Supplementary Table 2, available online). When lymph nodes 
with micro-metastases were regarded as metastatic nodes, the 
AUC values for mean stiffness, maximum stiffness, and the 
elasticity ratio were 0.774, 0.786, and 0.809, respectively (Fig-
ure 3B). 
DISCUSSION
Axillary lymph node metastasis is an important factor in 
the prognosis of patients with breast cancer. For this reason, 
SLN biopsy and frozen section evaluation is performed to as-
sess the metastatic status of axillary lymph nodes during the 
breast cancer surgery; axillary lymph node dissection is per-
formed if the SLNs harbor metastatic foci. However, the eval-
uation of intraoperative frozen section of SLN requires a pa-
thologist with breast cancer expertise capable of assessing fro-
zen sections; this prolongs the operation time and increases 
the total costs. We tested our hypothesis that ex vivo SWE is a 
reliable method to predict the presence of metastasis in ex-
cised axillary lymph node.
Since the development of elastography by Ophir and col-
leagues in 1990, its efficacy has been observed across several 
clinical fields, including disorders related to the thyroid, pros-
tate, kidney, and pancreas, and deep venous thrombosis [5,17]. 
In terms of breast pathology, many studies have been conduct-
ed to determine the usefulness of elastography in the diagnosis 
of various breast lesions; in this context, elastography is widely 
used in clinical practice [18-20]. These studies have revealed 
that the elasticity values of malignant lesions are higher than 
those of benign lesions. Moreover, the accuracy of the diagno-
sis is improved when SWE is added to conventional ultraso-
nography. In addition, studies on elastography for predicting 
axillary lymph node metastasis preoperatively have demon-
strated its advantage of being a noninvasiveness method. 
In our study, we assessed the elasticity values (mean stiff-
ness, maximum stiffness, and elasticity ratio) of excised axil-
lary lymph nodes using ex vivo SWE. The metastatic lymph 
nodes were larger, had higher values of mean and maximum 
stiffness, and a higher elasticity ratio than nonmetastatic 
lymph nodes. The mean sizes of metastatic and nonmetastatic 
lymph nodes were 10.5 mm and 7.5 mm. These findings were 
similar to findings in prior study that reported that metastatic 
lymph nodes were longer in the short and long axis and had a 
greater cortical thickness than nonmetastatic lymph nodes [1]. 
In contrast, another study reported no significant difference 
in the size of malignant and nonmalignant lymph nodes [11]. 
However, this study included only 11 metastatic lymph nodes 
and their size was relatively small (1.0–11.0 mm). 
In addition, both the mean and maximum stiffness of the 
metastatic lymph nodes were higher than that of the nonmet-
astatic lymph nodes. Tourasse et al. [11] reported mean stiff-
ness values of 17.5 and 11.3 kPa for metastatic and nonmeta-
static axillary lymph nodes, respectively, when the lymph 
nodes were assessed using in vivo SWE preoperatively. Kilic et 
al. [1] reported mean stiffness values of metastatic and non-
metastatic axillary lymph nodes of 25.5 kPa and 10.7 kPa, re-
spectively, when the lymph nodes were assessed by ex vivo 
SWE intraoperatively. In our study, the mean and maximum 
stiffness were higher than those previously reported. This is 
probably because we included 41 metastatic lymph nodes, 
whereas the authors included only 10s of nodes in the previ-
ous studies. The AUC values were 0.794 for mean stiffness 
and 0.802 for maximum stiffness. These were higher than the 
values of 0.762 for mean stiffness and 0.753 for maximum 
stiffness in an in vivo study; however, the mean stiffness is 
similar to the value of 0.786 for mean stiffness in an ex vivo 
study. Among the elasticity values, the elasticity ratio showed 
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the highest value with an odds ratio of 2.332, and an AUC of 
0.831. Several studies have reported that the elasticity ratio 
gives the best diagnostic performance in the evaluation of 
breast lesions by SWE [7,21]. This is because the elasticity ra-
tio is the value least affected by pre-compression [22]. More-
over, our elasticity values may be more accurate than those 
obtained in an in vivo study because pre-compression is lower 
when ex vivo SWE is performed. 
There are some limitations in our study. The greatest disad-
vantage of ultrasonography is its limited reproducibility [23]. 
However, when both B-mode ultrasound and SWE are ap-
plied for evaluating lesions, intraobserver and interobserver 
reproducibility of SWE is highly reliable for quantitative and 
qualitative assessment [24]. In a previous study, the intraob-
server reliability of node diameter was highly acceptable (in-
tra-class correlation coefficient [ICC], 0.94; 95% CI, 0.94–
0.95) as it was for mean stiffness (ICC, 0.87; 95% CI, 0.85–
0.88) and the elasticity ratio (ICC, 0.77; 95% CI, 0.74–0.79) of 
lymph nodes to the adjacent adipose tissue [24]. In addition, 
substantial interobserver agreement was noted for SWE ho-
mogeneity (κ= 0.66) and for maximum elasticity (κ= 0.80). 
The reproducibility of ultrasonographic examination, unlike 
that of in vivo examination of a breast mass, was likely to be 
higher in our study because we examined the ex vivo lymph 
nodes using better shear wave propagation; this allows better 
elastographic examination of the lymph nodes. In addition, 
our values of elasticity would be reliable because the SWE was 
performed by experienced radiologists. Another important 
limitation was that we did not count the exact time taken for 
intraoperative ex vivo SWE. Further research to investigate the 
effect of procedure on operation time is warranted. However, 
we expect that ex vivo SWE can be performed more rapidly 
than conventional frozen section evaluation of axillary lymph 
nodes due to the convenience of ex vivo SWE.
Despite these limitations, the surgeons could utilize intra-
operative ex vivo SWE to evaluate the metastatic status of ex-
cised lymph nodes under the guidance of radiologists because 
B-mode and SWE examination is easy to perform and does 
not require any additional instruments or agents apart from 
an ultrasound machine with an on-board elastic mode [9].
A validation study is needed to determine the usefulness of 
ex vivo SWE to intraoperatively predict metastasis of actual 
SLNs. If ex vivo SWE can predict the presence the metastasis 
in SLN as well as frozen examination, then the former tech-
nique can potentially be an alternative intraoperative method 
to evaluate SLNs. In conclusion, the ex vivo SWE showed that 
the larger size and the higher elasticity values, such as mean, 
maximum stiffness, and ratio, were significantly correlated 
with the presence of metastasis in axillary lymph nodes. It 
suggested that the intraoperative ex vivo SWE can be a feasible 
method to predict the presence of metastasis in axillary lymph 
nodes.
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